Schrodinger
Transforming industries through digital chemistry and material science: Schrödinger's collaborative platform drives innovation in drug discovery and research.
Schrodinger is a pioneering digital chemistry and material science company that utilizes advanced technology to drive collaborative drug discovery programs in both life sciences and materials science, transforming the way therapeutics are developed. Their offerings include computational chemistry tools like FEP+, BioLuminate, and Research Enablement Services, which are used across industries, and they provide industry-leading educational resources for learning digital chemistry. Schrödinger is actively engaging with the scientific community at events like the Lab of the Future Congress 2024 and has recently secured grants.
About Schrodinger
Schrodinger is a leading company in the field of digital chemistry and material science. They deploy their advanced platform to drive collaborative and proprietary drug discovery programs, transforming the way therapeutics are discovered in both life sciences and materials science. Schrödinger's mission is to improve human health and quality of life by leveraging digital chemistry.
Their offerings include a suite of products such as FEP+, BioLuminate, and Research Enablement Services. These tools enable teams across industries to apply Schrödinger technology for computational chemistry, medicinal chemistry, research IT, and structural biology applications. Schrödinger's educational resources, including online certification courses and free learning resources, are industry-leading and help learners master theoretical and applied sciences in a practical setting.
Schrödinger is actively participating in events like the Lab of the Future Congress 2024 to connect with scientific communities and share advancements in digital chemistry. They have reported recent grants and will announce fourth quarter and full-year financial results soon.
